Who is sponsoring NCT03932929?

NCT03932929 is sponsored by Hacettepe University.

What drugs are being tested in NCT03932929?

Interventions in NCT03932929: Scotchbond Universal Adhesive (3M ESPE).

What condition does NCT03932929 study?

NCT03932929 studies Non-Carious Cervical Lesions.

Is NCT03932929 still recruiting?

NCT03932929 is currently completed. Last updated 6 May 2019.

Last reviewed 2019-05-06 · How we verify

NCT03932929

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

36-Month Clinical Evaluation of a Universal Adhesive

Completed NA Last updated 6 May 2019

What this trial tests

NA trial testing Scotchbond Universal Adhesive (3M ESPE) in Non-Carious Cervical Lesions in 35 participants. Completed in 2 September 2018.

Timeline

2 September 2015

Primary endpoint
2 September 2018

2 September 2018

Quick facts

Lead sponsor	Hacettepe University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	35
Start date	2 September 2015
Primary completion	2 September 2018
Estimated completion	2 September 2018
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Scotchbond Universal Adhesive (3M ESPE)

Conditions studied

Non-Carious Cervical Lesions — all drugs for Non-Carious Cervical Lesions →

Sponsor

Hacettepe University

Who can join

Adults 18 to 81, any sex, with Non-Carious Cervical Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical trial was to evaluate and compare the performance of a universal adhesive with different adhesive strategies in the restoration of non-carious cervical lesions (NCCLs) over a 36-month period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03932929 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 6 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03932929.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing